Investing.com - Sesen Bio reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Sesen Bio announced earnings per share of $0.100 on revenue of $40M. Analysts polled by Investing.com anticipated EPS of $-0.120 on revenue of $0.00.
Sesen Bio shares are down 32% from the beginning of the year and are trading at $0.548 , down-from-52-week-high.
Sesen Bio shares gained 1.20% in intra-day trade the report.
Sesen Bio follows other major Healthcare sector earnings this month
Sesen Bio's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar